Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

Apertura Gene Therapy Series A round, April 26, 2022

Apertura Gene Therapy raised a Series A round for 67,000,000 USD in April, 2022.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Jan, 2023
Semyon Kolychev profile picture
Semyon Kolychev
edited on 23 Jan, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Date Announced
April 26, 2022
0
Funded Company
Apertura Gene Therapy
Apertura Gene Therapy
0
Funding Round Amount (USD)
67,000,0000
Funding Type
Series A
Series A
0
Investment
0
Funding Round Date
April 26, 2022
0
Edits on 24 Aug, 2022
"Created via: Web app"
Semyon Kolychev profile picture
Semyon Kolychev
created this topic on 24 Aug, 2022
Edits made to:
Infobox (+7 properties)
‌

 Apertura Gene Therapy Series A round, April 26, 2022

Infobox
Is a
Funding round
Funding round
Funding Type
Series A
Series A
Funded Company
Apertura Gene Therapy
Apertura Gene Therapy
Funding Round Amount (USD)
67,000,000
Date Announced
April 26, 2022
Investment
Announcement URL
https://www.biospace.com/article/releases/apertura-gene-therapy-launches-with-67m-series-a-financing-from-deerfield-and-an-innovative-technology-platform-to-develop-genetic-medicines/

Find more entities like Apertura Gene Therapy Series A round, April 26, 2022

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo